Blog
RSS FeedPosted by Michael Wonder on 12 Jun 2019
The Cancer Drugs Fund in practice and under the new framework
12 June 2019 - The Cancer Drugs Fund was established in 2010 to improve access to treatments not routinely available. ...
Posted by Michael Wonder on 31 Jan 2018
CDF to save NHS £140m over five years
31 January 2018 - At least £140 million is expected to be released into the NHS over the next five ...
Posted by Michael Wonder on 07 Jun 2017
Cancer Drugs Fund of minimal benefit
6 June 2017 - A new study has concluded that the medicines available in the previous version of the NHS Cancer ...
Posted by Michael Wonder on 26 May 2017
Conservatism and the cancer drugs fund
24 May 2017 - Are some patients—and some people— more deserving than others? ...
Posted by Michael Wonder on 01 May 2017
Cancer fund failure highlights the dilemma of drug pricing
1 May 2017 - The challenge is to keep treatments affordable but still encourage innovation. ...
Posted by Michael Wonder on 29 Apr 2017
Cancer Drugs Fund condemned as expensive and ineffective
28 April 2017 - Treatments approved by David Cameron’s scheme were not worth money, extended life very little and often had ...
Posted by Michael Wonder on 17 Nov 2016
NICE approves three quarters of CDF group 1 drugs for routine use
17 November 2016 - More than 75% of treatments in the Cancer Drugs Fund which have been looked at again by ...
Posted by Michael Wonder on 16 Nov 2016
Japan government panel halves price of cancer drug Opdivo
16 November 2016 - In an unprecedented move, a government panel decided Wednesday to cut the official price of cancer ...
Posted by Michael Wonder on 04 Oct 2016
Did it matter that the Cancer Drugs Fund was not NICE? A retrospective review
3 October 2016 - This article reviews the means by which the Cancer Drugs Fund made recent funding decisions for cancer ...
Posted by Michael Wonder on 29 Sep 2016
Cancer Drugs Fund requires further reform
27 September 2016 - Reliance on “real world” observational data undermines evidence base for clinical practice. ...
Posted by Michael Wonder on 11 Aug 2016
A novel UK approach to cancer access: yes, no, or maybe?
10 August 2016 - What are the implications of the new, reinvigorated Cancer Drugs Fund, for pharma and patients? ...
Posted by Michael Wonder on 10 Aug 2016
Cancer patients may lose vital drug in crackdown on funding: watchdog reviews 31 treatments that are not usually available on the NHS
10 August 2016 - The drug brentuximab vedotin may no longer be provided on the NHS. ...
Posted by Michael Wonder on 02 Aug 2016
Rare cancer drug which significantly delays progression of advanced thyroid cancer is left off relaunched Cancer Drugs Fund
2 August 2016 - People with radioiodine refractory differentiated thyroid cancer are overlooked as Lenvima (lenvatinib mesylate) is not scheduled for ...
Posted by Michael Wonder on 01 Aug 2016
Make drug makers pay: England’s strategy for cancer medicines
29 July 2016 - Roche, Pfizer concerned new system has no spending limit. ...
Posted by Michael Wonder on 30 Jul 2016
Cancer sufferers may lose access to effective drugs, says support group
29 July 2016 - Medicine regulator NICE will act as gatekeeper for new treatments, leading to fears NHS patients may be ...